Mechanisms of neuroprotective action of incretin mimetics
Recently, on the pharmacological market, new drugs from the class of incretin mimetics, or glucagon-like peptide-1 (GLP-1) receptor agonists, which have proven their high effectiveness in type 2 diabetes mellitus therapy, have appeared. At present, much attention has been paid to the pleotropic effe...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/d82c6f552639423ca0f5daca24988975 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|